Literature DB >> 28265208

Effectiveness of Early Invasive Therapy for Atrial Tachycardia in Adult Atrial-Baffle Survivors.

Elisa A Bradley, Ali N Zaidi, Justin Morrison, Curt J Daniels, Steven Kalbfleisch, Naomi J Kertesz.   

Abstract

Adults who underwent complex atrial baffling as children via Mustard or Senning procedures are at heightened risk for atrial arrhythmias. Antiarrhythmic therapies are typically ineffective in this population. Accordingly, our team of pediatric and adult electrophysiologists investigated the effectiveness of early invasive transbaffle-access techniques to perform early radiofrequency ablation at the source of these clinically significant arrhythmias. For this retrospective study, we selected 11 adult survivors of atrial baffling (mean age, 34 ± 9 yr) who underwent clinically indicated electrophysiologic study after no more than one trial of antiarrhythmic therapy. Using transbaffle-access techniques and 3-dimensional mapping of the venous atria, we found 12 inducible arrhythmias in 10 patients: intra-atrial reentrant tachycardia (n=6), atrioventricular nodal reentrant tachycardia (n=3), focal atrial tachycardia (n=2), and repetitive double firing of the atrioventricular node (n=1). Defining success as short- and midterm freedom from arrhythmia, we analyzed outcomes of radiofrequency ablation at 1 and 6 months. At 1 month, ablation was 100% successful. At 6 months, after 11 ablations in 9 patients, 5 patients had no clinical recurrence, 2 had improved arrhythmia control from minimal medical therapy, and 2 were to undergo repeat study for recurrent tachycardia. In the recurrence-free patients, arrhythmias during electrophysiology study matched the types found clinically before the study. To our knowledge, this is the largest one-year cohort of adult survivors of atrial baffling to have undergone study by a combined pediatric-adult electrophysiology team. We conclude that early invasive transbaffle access for ablating diverse atrial tachyarrhythmias was effective in these patients.

Entities:  

Keywords:  Arrhythmias, cardiac/epidemiology/etiology; body surface potential mapping/methods; catheter ablation/methods; electrophysiologic techniques, cardiac; postoperative complications; recurrence; retrospective studies; tachycardia/etiology; transposition of great vessels/complications/physiopathology/surgery; treatment outcome

Mesh:

Year:  2017        PMID: 28265208      PMCID: PMC5317354          DOI: 10.14503/THIJ-15-5470

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  11 in total

1.  Catheter ablation in transposition of the great arteries with Mustard or Senning baffles.

Authors:  Paul Khairy; George F Van Hare
Journal:  Heart Rhythm       Date:  2008-11-27       Impact factor: 6.343

2.  Characterization of reentrant circuits in left atrial macroreentrant tachycardia: critical isthmus block can prevent atrial tachycardia recurrence.

Authors:  Feifan Ouyang; Sabine Ernst; Thomas Vogtmann; Masahiko Goya; Marius Volkmer; Anselm Schaumann; Dietmar Bänsch; Matthias Antz; Karl-Heinz Kuck
Journal:  Circulation       Date:  2002-04-23       Impact factor: 29.690

3.  Radiofrequency catheter ablation of supraventricular tachycardia substrates after mustard and senning operations for d-transposition of the great arteries.

Authors:  R J Kanter; J Papagiannis; M P Carboni; R M Ungerleider; W E Sanders; J M Wharton
Journal:  J Am Coll Cardiol       Date:  2000-02       Impact factor: 24.094

4.  Arrhythmia and mortality after the Mustard procedure: a 30-year single-center experience.

Authors:  M Gelatt; R M Hamilton; B W McCrindle; M Connelly; A Davis; L Harris; R M Gow; W G Williams; G A Trusler; R M Freedom
Journal:  J Am Coll Cardiol       Date:  1997-01       Impact factor: 24.094

5.  Anatomic correction of transposition of the great vessels.

Authors:  A D Jatene; V F Fontes; P P Paulista; L C Souza; F Neger; M Galantier; J E Sousa
Journal:  J Thorac Cardiovasc Surg       Date:  1976-09       Impact factor: 5.209

6.  Radiofrequency-assisted transseptal perforation for electrophysiology procedures in children and adults with repaired congenital heart disease.

Authors:  Jesse J Esch; John K Triedman; Frank Cecchin; Mark E Alexander; Edward P Walsh
Journal:  Pacing Clin Electrophysiol       Date:  2013-02-04       Impact factor: 1.976

7.  Acute and long-term outcome after catheter ablation of supraventricular tachycardia in patients after the Mustard or Senning operation for D-transposition of the great arteries.

Authors:  Jinjin Wu; Isabel Deisenhofer; Sonja Ammar; Stephanie Fichtner; Tilko Reents; Pinjun Zhu; Clemens Jilek; Christof Kolb; John Hess; Gabriele Hessling
Journal:  Europace       Date:  2013-01-25       Impact factor: 5.214

8.  Outcome of intra-atrial re-entrant tachycardia catheter ablation in adults with congenital heart disease: negative impact of age and complex atrial surgery.

Authors:  Sing-Chien Yap; Louise Harris; Candice K Silversides; Eugene Downar; Vijay S Chauhan
Journal:  J Am Coll Cardiol       Date:  2010-11-02       Impact factor: 24.094

9.  Characteristics of atrial tachycardia due to small vs large reentrant circuits after ablation of persistent atrial fibrillation.

Authors:  Miki Yokokawa; Rakesh Latchamsetty; Hamid Ghanbari; Diego Belardi; Akash Makkar; Brett Roberts; Wouter Saint-Phard; Mohamad Sinno; Thomas Carrigan; Robert Kennedy; Arisara Suwanagool; Eric Good; Thomas Crawford; Krit Jongnarangsin; Frank Pelosi; Frank Bogun; Hakan Oral; Fred Morady; Aman Chugh
Journal:  Heart Rhythm       Date:  2012-12-22       Impact factor: 6.343

10.  Transbaffle mapping and ablation for atrial tachycardias after mustard, senning, or Fontan operations.

Authors:  Rafael Correa; Edward P Walsh; Mark E Alexander; Douglas Y Mah; Frank Cecchin; Dominic J Abrams; John K Triedman
Journal:  J Am Heart Assoc       Date:  2013-09-19       Impact factor: 5.501

View more
  1 in total

Review 1.  Management of Heart Failure in Adult Congenital Heart Disease.

Authors:  Aarthi Sabanayagam; Omer Cavus; Jordan Williams; Elisa Bradley
Journal:  Heart Fail Clin       Date:  2018-08-20       Impact factor: 3.179

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.